Wojciech Polkowski

Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study

Sandra M. Swain, David Miles, Sung‐Bae Kim et al. · The Lancet Oncology · 2020 · 898 citations

Medicine, Oncology, Pharmacology +14

Long-course oxaliplatin-based preoperative chemoradiation versus 5 × 5 Gy and consolidation chemotherapy for cT4 or fixed cT3 rectal cancer: results of a randomized phase III study

Krzysztof Bujko, Lucjan Wyrwicz, Andrzej Rutkowski et al. · Annals of Oncology · 2016 · 444 citations · Full text

Medicine, Oncology, Surgery +17

Long-course preoperative chemoradiation versus 5 × 5 Gy and consolidation chemotherapy for clinical T4 and fixed clinical T3 rectal cancer: long-term results of the randomized Polish II study

Bogumiła Ciseł, Lucyna Pietrzak, Wojciech Michalski et al. · Annals of Oncology · 2019 · 310 citations · Full text

Medicine, Oncology, Surgery +17

Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trial

Jayant S. Vaidya, Max Bulsara, Michael Baum et al. · BMJ · 2020 · 289 citations · Full text

Medicine, Oncology, Surgery +17

Myeloid-Derived Suppressor Cells Endow Stem-like Qualities to Breast Cancer Cells through IL6/STAT3 and NO/NOTCH Cross-talk Signaling

Dongjun Peng, Takashi Tanikawa, Wei Li et al. · Cancer Research · 2016 · 272 citations · Full text

Medicine, Immunology, Oncology +17